Overview #
Alcohol in toner is one of those formulation decisions that looks simple on the surface and gets complicated fast once you factor in three different regulatory frameworks. The EU, FDA, and NMPA don’t agree on everything here — and the gaps between them have real consequences for labeling, safety dossiers, and registration timelines. We’ve had brand partners come to us with a single global SKU brief, and the first thing we do is pull up all three frameworks side by side, because what clears in the US doesn’t always clear in China without additional documentation. This guide covers what we actually prepare for brand partners navigating multi-market toner launches with ethanol in the formula.
Ethanol in Toner: What the Regulations Actually Say #
Let’s start with the EU, because it sets the most documentation-heavy baseline. Under EU Cosmetics Regulation 1223/2009, ethanol (ethyl alcohol) is not a restricted ingredient in the conventional sense — it doesn’t appear in Annex II (prohibited) or Annex III (restricted with limits). That sounds permissive. It is, until you factor in the Product Safety Report (CPSR) requirement. Every EU cosmetic needs a qualified safety assessor to sign off, and when ethanol sits above roughly 20% in a leave-on product like a toner, assessors start asking harder questions about cumulative dermal exposure and barrier disruption. We’ve seen CPSRs come back with requests for additional toxicological justification at concentrations above 25% in leave-on formats.
The FDA position is more relaxed in structure. Under FDA Cosmetics Guidelines, ethanol in a cosmetic toner is regulated as a cosmetic ingredient — no pre-market approval, no concentration ceiling in the regulations themselves. The practical ceiling is set by your safety substantiation obligation under the FD&C Act. If you’re selling an astringent toner with an OTC drug claim (acne, for example), you’re now in OTC drug territory and ethanol becomes an active ingredient with its own monograph requirements. Most brand partners don’t realize that “pore-tightening” language can push a toner into OTC classification. We flag this early.
China is the most prescriptive of the three. The NMPA Cosmetic Regulation framework — specifically the 2021 Cosmetic Supervision and Administration Regulation (CSAR) and its implementing rules — classifies ethanol as a permitted cosmetic ingredient. For ordinary cosmetics (普通化妆品), ethanol doesn’t trigger special registration requirements on its own. But NMPA’s safety assessment guidelines require quantitative risk assessment for ingredients with known skin sensitization or barrier disruption potential when used at higher concentrations. In practice, our regulatory team recommends keeping ethanol below 20% in toners targeting the China market if you want a clean path through filing. Above that, expect the safety assessor to add a dermal absorption calculation to the dossier.
One thing that cuts across all three markets: denatured alcohol is treated differently from pure ethanol in labeling. In the EU and US, SD Alcohol (specially denatured) must be declared as such on the INCI list. In China, the ingredient declaration follows GB/T 13517 conventions, and the denaturant itself may require separate listing. We’ve had one batch of documentation rejected by a China filing agent because the denaturant (isopropyl alcohol at 5% of the alcohol fraction) wasn’t separately declared. Small detail. Real consequence.
Skin Barrier Impact: The Clinical Picture #
Honestly, most brands underestimate how much the barrier disruption data matters to regulators — not just to dermatologists. The SCCS Scientific Opinion framework explicitly requires safety assessors to consider local effects on skin integrity, and ethanol’s effect on the stratum corneum lipid matrix is well-documented enough that it will come up in any serious CPSR review.
The head-to-head data is actually pretty clear here. One double-blind, randomized controlled trial (n=30, 8 weeks, twice-daily application) measured transepidermal water loss (TEWL) in subjects using a toner at 40% ethanol versus a matched alcohol-free formulation. The 40% ethanol group showed a mean TEWL increase of 18% from baseline by week 4, partially recovering by week 8. The alcohol-free group showed no significant TEWL change. What that study doesn’t capture — and what we see in our own stability and consumer testing — is the interaction between ethanol concentration and the rest of the formula. A toner with 15% ethanol, 5% glycerin, and 2% panthenol behaves very differently at the barrier level than a 15% ethanol toner with no humectants. The humectant offset is real, but it’s not a free pass.
For our toner and essence formulation work, we typically model three ethanol tiers: below 10% (minimal barrier concern, broad market access), 10–25% (requires humectant balancing and safety assessor attention in EU), and above 25% (we almost always push back on this brief for leave-on formats unless there’s a specific functional rationale). The third tier isn’t impossible to formulate safely, but the documentation burden goes up and the consumer complaint risk goes up with it.
By week 8 of accelerated stability testing, we also see something worth noting: ethanol above 20% accelerates fragrance oxidation in toners stored at 40°C/75% RH. We’ve had two projects where the fragrance profile shifted noticeably at the 3-month mark under those conditions. The formula passed safety. The consumer experience didn’t.
Labeling Requirements by Market #
This is usually where projects go sideways — not the formulation, the label.
In the EU, ethanol must appear on the INCI list as “Alcohol” (if undenatered) or “Alcohol Denat.” (if denatured). The concentration doesn’t appear on the consumer label, but it must be documented in the Product Information File (PIF). If your toner makes any claim that references the alcohol — “alcohol-free toning,” for example — you need substantiation in the PIF. The EU also requires the standard 12-symbol PAO (period after opening) and the full responsible person address within the EU or UK (post-Brexit, these are separate).
FDA labeling for cosmetics follows 21 CFR Part 701. Ingredients are listed in descending order of predominance. “Alcohol” or “SD Alcohol 40-B” (or whichever SD designation applies) must appear in the correct position. No concentration disclosure required on the consumer label. If the product crosses into OTC drug territory, you’re now under 21 CFR Part 201 and the format changes entirely — Drug Facts panel, active ingredient with percentage, the works.
China’s GB 5296.3 standard governs cosmetic labeling. Full ingredient list in Chinese (中文成分表) is mandatory, following INCI names transliterated or translated per the official NMPA ingredient database. Ethanol appears as 乙醇. The concentration is not disclosed on the consumer label, but it must appear in the registration or filing dossier. For ordinary cosmetics filed through the new online system, the ingredient list in the dossier must match the label exactly — we’ve seen rejections for minor discrepancies between the two.
One market-specific wrinkle: South Korea (not covered in the main three, but we get asked constantly) requires ethanol concentration disclosure in the full ingredient list if it exceeds 10%. Worth knowing if your brand has APAC ambitions beyond China.
The Regulatory Comparison: EU vs. FDA vs. NMPA #
| Regulatory Dimension | EU (Reg. 1223/2009) | US FDA (FD&C Act) | China NMPA (CSAR 2021) |
|---|---|---|---|
| Ethanol permitted? | Yes, no concentration limit in Annexes | Yes, no cosmetic concentration limit | Yes, listed as permitted ingredient |
| Safety assessment required? | Yes — CPSR by qualified assessor mandatory | Yes — safety substantiation required, no prescribed format | Yes — quantitative risk assessment for higher concentrations |
| Pre-market registration? | No (notification via CPNP portal) | No (cosmetic); Yes if OTC drug claim | Filing required (普通化妆品 filing, not full registration) |
| Label disclosure of concentration? | No (PIF only) | No (unless OTC drug) | No (dossier only) |
| “Alcohol Denat.” labeling? | Yes — must declare denaturant type | Yes — SD Alcohol designation required | Denaturant may require separate INCI declaration |
| Typical timeline (new product) | 4–8 weeks (CPNP notification post-CPSR) | 2–4 weeks (label review + safety file) | 3–6 months (ordinary cosmetics filing) |
| Key risk trigger | CPSR rejection above ~20% in leave-on | OTC drug claim reclassification | Dossier-label mismatch; safety assessment gaps |
The timeline gap between China and the other two markets is the one that catches brands off guard most often. A toner that’s ready to ship to the EU in 6 weeks can sit in China filing for 4 months. We plan for this from the brief stage.
Where Most Brands Get This Wrong #
The most common mistake we see: a brand finalizes the formula and the EU/US label, then comes to us and says “now we need to file in China.” At that point, if the ethanol is at 22% and the formula has a fragrance component that isn’t in the NMPA permitted list, you’re looking at a reformulation, not just a filing. We’ve had to rebuild toners from scratch at that stage. It’s expensive and it delays launch by 3–4 months minimum.
The second mistake is conflating “alcohol-free” claims with regulatory compliance. “Alcohol-free” on a EU or US label means no ethyl alcohol — but cetyl alcohol, stearyl alcohol, and other fatty alcohols are still “alcohols” in chemistry. Consumers and some regulators interpret this differently. The SCCS Scientific Opinion framework doesn’t restrict fatty alcohols the same way, but a claim of “alcohol-free” that includes cetearyl alcohol has generated consumer complaints and, in some EU markets, advertising standards challenges. We now require brand partners to specify exactly what they mean by “alcohol-free” before we finalize the brief.
There’s also a quiet trend we’re watching: EU responsible persons are increasingly asking for ethanol sourcing documentation — specifically, whether the ethanol is synthetic or bio-based, and whether it carries any GMO-derived status. This isn’t in the regulation yet. But we’ve seen it come up in three CPSR reviews in the past 18 months. Our current approach is to source bio-based, non-GMO ethanol by default for EU-destined products and document the supply chain. It adds a small cost — roughly €0.02–0.04 per unit at typical toner fill weights — but it prevents questions later.
For brands working on acid exfoliation toners that combine ethanol with AHAs, there’s an additional layer: drop below pH 3.5 and you’re in regulatory grey territory in the EU. Most brands don’t realize this until we tell them. The ethanol doesn’t change the pH classification, but it does affect the penetration enhancement of the acid, which some CPSR assessors flag as a reason to require additional in vitro penetration data.
Formulation Notes for Brand Partners #
What market? What are you expecting on-pack? Those are the first two questions we ask when a brand comes to us with a toner brief that includes ethanol.
If the answer is “global launch, EU + US + China simultaneously,” we start at 15% ethanol or below. That concentration gives you the sensory profile most brands want — the quick-dry, slightly astringent feel — without triggering the documentation escalations in any of the three markets. We pair it with 3–5% glycerin and 1% panthenol to offset TEWL impact, and we use undenatered ethanol for China filing simplicity.
If the brief is EU + US only and the brand wants a higher-alcohol “clarifying” toner, we can work up to 25% with the right humectant system and a CPSR assessor we trust. Above 25%, we want a functional rationale in writing — not just “it feels premium.” We’ve stopped taking briefs that say “high alcohol for the luxury feel” without a corresponding active delivery rationale, because the safety documentation burden isn’t worth it for a sensory preference.
China-only or China-first briefs get a different conversation. We keep ethanol at or below 20%, we pre-check every fragrance component against the NMPA permitted list before finalizing the formula, and we build the safety assessment dossier in parallel with stability testing rather than after. That parallel workflow saves 6–8 weeks on the filing timeline. The ICH Stability Guidelines inform our stability protocol design even for cosmetics — 40°C/75% RH for 6 months, with interim reads at 1, 3, and 6 months.
Packaging matters too. Airless pump formats reduce ethanol evaporation during use and extend the effective shelf life of the formula. The cost premium is real — airless pump adds roughly $0.50–$0.90 per unit at MOQ 3,000 — but for a toner with active ingredients that are ethanol-sensitive (niacinamide discoloration, for example), it’s often the right call.
Frequently Asked Questions #
Q: We want to label our toner “alcohol-free” — does that mean zero ethanol, or can we use fatty alcohols?
In the EU and US, “alcohol-free” is understood by regulators and most consumers to mean no ethyl alcohol (ethanol). Fatty alcohols like cetearyl alcohol or cetyl alcohol are technically alcohols but are not restricted by this claim. That said, we’ve seen advertising standards complaints in Germany and the UK when fatty alcohols appear in “alcohol-free” products, so we recommend adding “contains no ethyl alcohol” as a clarifying sub-claim if your formula includes fatty alcohols above 1%.
Q: What’s the maximum ethanol concentration we can use in a toner for the China market without triggering extra safety review?
There’s no hard regulatory ceiling in the NMPA rules, but in practice we keep it at or below 20% for ordinary cosmetics filing. Above that, the safety assessor will require a quantitative dermal exposure calculation and may request additional in vitro data. That adds 4–6 weeks to the dossier preparation timeline and increases safety assessment fees by roughly 15–20%.
Q: Our EU responsible person is asking for ethanol sourcing documentation. Is that a standard requirement?
It’s not in EU Cosmetics Regulation 1223/2009 as a formal requirement, but we’re seeing it more frequently in CPSR reviews — particularly for bio-based or natural-positioned products. We now provide a Certificate of Origin and a non-GMO declaration for all ethanol used in EU-destined formulas as standard practice. It costs almost nothing to prepare and prevents delays.
Q: How long does China NMPA filing take for a toner with ethanol?
For ordinary cosmetics (普通化妆品), the online filing process typically takes 3–6 months from dossier submission to approval, assuming no deficiency notices. If the safety assessment is incomplete or the ingredient list has discrepancies, add another 6–8 weeks per round of corrections. We’ve completed filings in as few as 11 weeks when the dossier was fully prepared before submission — that’s the exception, not the rule.
Q: Can we use SD Alcohol (denatured ethanol) in a toner for all three markets?
Yes, but the labeling and documentation requirements differ. In the EU, it must be declared as “Alcohol Denat.” with the denaturant type documented in the PIF. In the US, the specific SD Alcohol designation (e.g., SD Alcohol 40-B) must appear on the label per 21 CFR Part 701. In China, the denaturant may need to be listed as a separate ingredient in the dossier. We recommend using the same SD Alcohol grade across all markets and preparing market-specific label versions — the formula stays the same, the declarations change.
Have a product concept in mind? Contact our formulation team to request a complimentary brief review.
© 2026 Mastracare.com. All rights reserved.
Unauthorized reproduction or distribution is prohibited.